The Victorian Government will invest in new critical manufacturing technology and research to provide certainty of supply of new vaccines and lifesaving treatments in Australia.
Following the Commonwealth identifying onshore production of mRNA vaccines as a national priority, Victoria will provide $50 million to establish mRNA vaccine and therapeutic manufacturing in Melbourne, through partnerships with our world-class Victorian universities, leading researchers, and Australian and international manufacturing companies, an official press release said.
Victoria is ideally placed to lead in mRNA manufacturing and the production of mRNA vaccines and therapeutics and the Victorian Government will work closely with the Commonwealth and world-leading experts from Monash University, the University of Melbourne, The Doherty Institute and other leading research institutes to develop the first mRNA manufacturing capability in the Southern Hemisphere.
mRNA vaccines are a promising alternative to traditional vaccines because of their high efficacy, capacity for rapid development, low-cost manufacture, and safe administration. This has been highlighted by the success of the mRNA COVID-19 vaccines from Pfizer/BioNTech and Moderna which are manufactured in Europe and the United States.
Developing mRNA manufacturing capability locally in Victoria would provide vaccine security, ensuring manufacturing can be contracted locally to avoid global supply chain issues and creating a more robust defence against future pandemics.
Increasingly, mRNA and other forms of RNA nanomedicines can be used in the treatment of cancer, rare diseases, cellular engineering and protein-replacement therapy. This investment will help accelerate RNA-based projects and develop new lifesaving treatments.
Victoria continues to be a world leader in infectious disease research with funding committed to help establish the Australian Institutes for Infectious Diseases, and will soon be home to the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere.
The Government welcomes the opportunity to work with the Commonwealth to secure mRNA manufacturing capability for the benefit of all Australians. Further investment to support delivery of mRNA vaccines in Victoria may be considered through the Breakthrough Victoria Fund.
Acting Premier James Merlino said, “It’s vital that we can develop and manufacture mRNA vaccines and treatments locally to ensure we have vaccine security here in Australia and across our region.”
Follow The Indian Sun on Twitter | Instagram | Facebook
Support Independent Community Journalism
Dear Reader,The Indian Sun exists for one reason: to tell stories that might otherwise go unheard.
We report on local councils, state politics, small businesses and cultural festivals. We focus on the Indian diaspora and the wider multicultural community with care, balance and accountability. We publish in print and online, send regular newsletters and produce video content. We also run media training programs to help community organisations share their own stories.
We operate independently.
Community journalism does not have the backing of large media corporations. Advertising revenue fluctuates. Platform algorithms change. Costs continue to rise. Yet the need for credible, grounded reporting in a multicultural Australia has never been greater.
When you support The Indian Sun, you support:
• Independent reporting on issues affecting migrant communities
• Coverage of local and state decisions that shape daily life
• A platform for small businesses and community groups
• Media training that builds skills within the community
• Journalism accountable to readers
We cannot cover everything, but we work to cover what matters.
If you value thoughtful reporting that reflects Australia’s diversity, we invite you to contribute. Every donation helps us maintain the quality and consistency of our work.
Please consider making a contribution today.
Thank you for your support.
The Indian Sun Team
